Quest Diagnostics (DGX) Enterprise Value (2016 - 2025)
Quest Diagnostics (DGX) has disclosed Enterprise Value for 17 consecutive years, with -$340.0 million as the latest value for Q4 2025.
- Quarterly Enterprise Value rose 33.85% to -$340.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$340.0 million through Dec 2025, up 33.85% year-over-year, with the annual reading at -$340.0 million for FY2025, 33.85% up from the prior year.
- Enterprise Value hit -$340.0 million in Q4 2025 for Quest Diagnostics, up from -$351.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$49.0 million in Q2 2023 to a low of -$1.2 billion in Q1 2021.
- Historically, Enterprise Value has averaged -$479.6 million across 5 years, with a median of -$459.5 million in 2021.
- Biggest five-year swings in Enterprise Value: skyrocketed 93.13% in 2023 and later crashed 551.43% in 2024.
- Year by year, Enterprise Value stood at -$833.0 million in 2021, then soared by 71.43% to -$238.0 million in 2022, then tumbled by 173.53% to -$651.0 million in 2023, then grew by 21.04% to -$514.0 million in 2024, then skyrocketed by 33.85% to -$340.0 million in 2025.
- Business Quant data shows Enterprise Value for DGX at -$340.0 million in Q4 2025, -$351.0 million in Q3 2025, and -$282.0 million in Q2 2025.